Complex Relationship between Ligand Binding and Dimerization in the Epidermal Growth Factor Receptor

Cell Reports

Volumn 9, Issue 4, 2014, Pages 1306-1317

  Bessman, Nicholas J ^a   Bagchi, Atrish ^a   Ferguson, Kathryn M ^a   Lemmon, Mark A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR; FC RECEPTOR; LIGAND; MUTANT PROTEIN; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; DIMERIZATION; DROSOPHILA; ENZYME SPECIFICITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; GENE MUTATION; GENETIC LINKAGE; GLIOBLASTOMA; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; REGULATORY MECHANISM; THERMODYNAMICS; CALORIMETRY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SOLUBILITY;

CALORIMETRY; EPIDERMAL GROWTH FACTOR; GLIOBLASTOMA; HUMANS; LIGANDS; MODELS, MOLECULAR; MUTANT PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FC; SOLUBILITY; THERMODYNAMICS;

EID: 84912114619     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.10.010     Document Type: Article

References (45)

1. Adak S., Yang K.S., Macdonald-Obermann J., Pike L.J. The membrane-proximal intracellular domain of the epidermal growth factor receptor underlies negative cooperativity in ligand binding. J.Biol. Chem. 2011, 286:45146-45155.
2. Adams T.E., Koziolek E.J., Hoyne P.H., Bentley J.D., Lu L., Lovrecz G., Ward C.W., Lee F.T., Scott A.M., Nash A.D., et al. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity invivo. Growth Factors 2009, 27:141-154.
3. Alvarado D., Klein D.E., Lemmon M.A. ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor. Nature 2009, 461:287-291.
4. Alvarado D., Klein D.E., Lemmon M.A. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 2010, 142:568-579.
5. Arkhipov A., Shan Y., Das R., Endres N.F., Eastwood M.P., Wemmer D.E., Kuriyan J., Shaw D.E. Architecture and membrane interactions of the EGF receptor. Cell 2013, 152:557-569.
6. Bass J., Kurose T., Pashmforoush M., Steiner D.F. Fusion of insulin receptor ectodomains to immunoglobulin constant domains reproduces high-affinity insulin binding invitro. J.Biol. Chem. 1996, 271:19367-19375.
7. Bessman N.J., Lemmon M.A. Finding the missing links in EGFR. Nat. Struct. Mol. Biol. 2012, 19:1-3.
8. Brennan C.W., Verhaak R.G., McKenna A., Campos B., Noushmehr H., Salama S.R., Zheng S., Chakravarty D., Sanborn J.Z., Berman S.H., et al. The somatic genomic landscape of glioblastoma. Cell 2013, 155:462-477. TCGA Research Network.
9. Burgess A.W., Cho H.S., Eigenbrot C., Ferguson K.M., Garrett T.P.J., Leahy D.J., Lemmon M.A., Sliwkowski M.X., Ward C.W., Yokoyama S. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Mol. Cell 2003, 12:541-552.
10. Chantry A. The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors. J.Biol. Chem. 1995, 270:3068-3073.
11. Dawson J.P., Berger M.B., Lin D., Schlessinger J., Lemmon M.A., Ferguson K.M. EGF receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol. Cell. Biol. 2005, 25:7734-7742.
12. Dawson J.P., Bu Z., Lemmon M.A. Ligand-induced structural transitions in ErbB receptor extracellular domains. Structure 2007, 15:942-954.
13. De Meyts P. The insulin receptor: a prototype for dimeric, allosteric membrane receptors?. Trends Biochem. Sci. 2008, 33:376-384.
14. Defize L.H., Boonstra J., Meisenhelder J., Kruijer W., Tertoolen L.G., Tilly B.C., Hunter T., van Bergen en Henegouwen P.M., Moolenaar W.H., de Laat S.W. Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J.Cell Biol. 1989, 109:2495-2507.
15. Elleman T.C., Domagala T., McKern N.M., Nerrie M., Lönnqvist B., Adams T.E., Lewis J., Lovrecz G.O., Hoyne P.A., Richards K.M., et al. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. Biochemistry 2001, 40:8930-8939.
16. Endres N.F., Das R., Smith A.W., Arkhipov A., Kovacs E., Huang Y., Pelton J.G., Shan Y., Shaw D.E., Wemmer D.E., et al. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 2013, 152:543-556.
17. Ferguson K.M., Darling P.J., Mohan M.J., Macatee T.L., Lemmon M.A. Extracellular domains drive homo- but not hetero-dimerization of erbB receptors. EMBO J. 2000, 19:4632-4643.
18. Ferguson K.M., Berger M.B., Mendrola J.M., Cho H.S., Leahy D.J., Lemmon M.A. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol. Cell 2003, 11:507-517.
19. Garrett T.P.J., McKern N.M., Lou M., Elleman T.C., Adams T.E., Lovrecz G.O., Zhu H.J., Walker F., Frenkel M.J., Hoyne P.A., et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 2002, 110:763-773.
20. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997, 16:1647-1655.
21. Hoyne P.A., Cosgrove L.J., McKern N.M., Bentley J.D., Ivancic N., Elleman T.C., Ward C.W. High affinity insulin binding by soluble insulin receptor extracellular domain fused to a leucine zipper. FEBS Lett. 2000, 479:15-18.
22. Jaiswal B.S., Kljavin N.M., Stawiski E.W., Chan E., Parikh C., Durinck S., Chaudhuri S., Pujara K., Guillory J., Edgar K.A., et al. Oncogenic ERBB3 mutations in human cancers. Cancer Cell 2013, 23:603-617.
23. Jones J.T., Akita R.W., Sliwkowski M.X. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 1999, 447:227-231.
24. Jura N., Endres N.F., Engel K., Deindl S., Das R., Lamers M.H., Wemmer D.E., Zhang X., Kuriyan J. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 2009, 137:1293-1307.
25. Lax I., Mitra A.K., Ravera C., Hurwitz D.R., Rubinstein M., Ullrich A., Stroud R.M., Schlessinger J. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain. J.Biol. Chem. 1991, 266:13828-13833.
26. Lee J.C., Vivanco I., Beroukhim R., Huang J.H., Feng W.L., DeBiasi R.M., Yoshimoto K., King J.C., Nghiemphu P., Yuza Y., et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006, 3:e485.
27. Lemmon M.A., Bu Z., Ladbury J.E., Zhou M., Pinchasi D., Lax I., Engelman D.M., Schlessinger J. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 1997, 16:281-294.
28. Lemmon M.A., Schlessinger J., Ferguson K.M. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb. Perspect. Biol. 2014, 6:a020768.
29. Li S., Schmitz K.R., Jeffrey P.D., Wiltzius J.J., Kussie P., Ferguson K.M. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 2005, 7:301-311.
30. Li Y., Macdonald-Obermann J., Westfall C., Piwnica-Worms D., Pike L.J. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization. J.Biol. Chem. 2012, 287:31116-31125.
31. Liu P., Cleveland T.E., Bouyain S., Byrne P.O., Longo P.A., Leahy D.J. A single ligand is sufficient to activate EGFR dimers. Proc. Natl. Acad. Sci. USA 2012, 109:10861-10866.
32. Livingstone J.R., Spolar R.S., Record M.T. Contribution to the thermodynamics of protein folding from the reduction in water-accessible nonpolar surface area. Biochemistry 1991, 30:4237-4244.
33. Lu C., Mi L.Z., Grey M.J., Zhu J., Graef E., Yokoyama S., Springer T.A. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol. Cell. Biol. 2010, 30:5432-5443.
34. Lu C., Mi L.Z., Schürpf T., Walz T., Springer T.A. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor. J.Biol. Chem. 2012, 287:38244-38253.
35. Macdonald J.L., Pike L.J. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proc. Natl. Acad. Sci. USA 2008, 105:112-117.
36. Macdonald-Obermann J.L., Pike L.J. The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding. J.Biol. Chem. 2009, 284:13570-13576.
37. Magun B.E., Matrisian L.M., Bowden G.T. Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number. J.Biol. Chem. 1980, 255:6373-6381.
38. Mattoon D., Klein P., Lemmon M.A., Lax I., Schlessinger J. The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function. Proc. Natl. Acad. Sci. USA 2004, 101:923-928.
39. Mi L.Z., Lu C., Li Z., Nishida N., Walz T., Springer T.A. Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat. Struct. Mol. Biol. 2011, 18:984-989.
40. Ogiso H., Ishitani R., Nureki O., Fukai S., Yamanaka M., Kim J.H., Saito K., Sakamoto A., Inoue M., Shirouzu M., Yokoyama S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002, 110:775-787.
41. Red Brewer M., Choi S.H., Alvarado D., Moravcevic K., Pozzi A., Lemmon M.A., Carpenter G. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 2009, 34:641-651.
42. Surinya K.H., Forbes B.E., Occhiodoro F., Booker G.W., Francis G.L., Siddle K., Wallace J.C., Cosgrove L.J. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors. J.Biol. Chem. 2008, 283:5355-5363.
43. Vivanco I., Robins H.I., Rohle D., Campos C., Grommes C., Nghiemphu P.L., Kubek S., Oldrini B., Chheda M.G., Yannuzzi N., et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov. 2012, 2:458-471.
44. Walker F., Orchard S.G., Jorissen R.N., Hall N.E., Zhang H.H., Hoyne P.A., Adams T.E., Johns T.G., Ward C., Garrett T.P.J., et al. CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor. J.Biol. Chem. 2004, 279:22387-22398.
45. Wilson K.J., Gilmore J.L., Foley J., Lemmon M.A., Riese D.J. Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol. Ther. 2009, 122:1-8.